TestingMassachusetts-Apr 11, 2023

Massachusetts Recalls Cannabis Products Over Faulty Microbial Test Kits

Key Takeaway

The Massachusetts Cannabis Control Commission issued a regulatory bulletin after Medicinal Genomics recalled microbial testing kits that had been widely used across licensed Massachusetts testing facilities. Products that had passed microbial safety screening using the faulty kits may have entered the retail market without proper contaminant detection, creating potential consumer safety concerns. The recall affected dozens of cultivators and manufacturers whose products were tested during the affected period. The Massachusetts CCC directed affected operators to retest inventory and coordinate voluntary recalls where necessary. For cannabis operators, the incident highlighted the downstream risks of testing kit quality failures and reinforced the importance of chain-of-custody documentation at every stage.

What This Means for Cannabis Businesses

Testing developments affect product safety, consumer trust, and regulatory compliance across the supply chain. Lab testing integrity is fundamental to the legal cannabis market - when labs fail or commit fraud, it undermines the entire system and puts consumers at risk. Operators should verify their testing lab's accreditation status and review COAs carefully for any irregularities.

Massachusetts Cannabis Market Overview

Massachusetts has a well-regulated cannabis market with comprehensive open data. The state allows consumption lounges and publishes license data in accessible formats. The state has approximately 800 active cannabis licenses and 16 licensed testing laboratories. There are 48 cannabis professionals serving Massachusetts businesses on our directory, including CPAs, attorneys, and compliance consultants.

This analysis is based on reporting by Massachusetts CCC. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.